Representative Publications: |
Moeller, S. J., Gil, R., Weinstein, J. J., Baumvoll, T., Wengler, K., Fallon, N., Van Snellenberg, J. X., Abeykoon, S., Perlman, G., Williams, J., Manu, L., Slifstein, M., Cassidy, C. M., Martinez, D. M., & Abi-Dargham, A. (2022). Deep rTMS of the insula and prefrontal cortex in smokers with schizophrenia: proof-of-concept study. Schizophrenia, 8(1), 6. PMCID: PMC8881463.
Maracic, C. E., & Moeller, S. J. (2021). Neural and behavioral correlates of impaired insight and self-awareness in substance use disorder. Current Behavioral Neuroscience Reports, 8(4), 113-123. PMCID: PMC9374000.
Moeller, S. J., Hanley, A. D., & Garland, E. L. (2020). Behavioral preference for viewing drug versus pleasant images predicts current and future opioid misuse among chronic pain patients. Psychological Medicine, 50(4), 644-652. PMCID: PMC7413318.
Moeller, S. J., Kundu, P., Bachi, K., Maloney, T., Malaker, P., Parvaz, M. A., Alia-Klein, N., London, E. D., & Goldstein, R. Z. (2020). Self-awareness of problematic drug use: a new fMRI task to assess underlying neurocircuitry. Drug and Alcohol Dependence, 209, 107930. PMCID: PMC7170015.
Moeller, S. J., Zilverstand, Z., Konova, A. B., Kundu, P., Parvaz, M. A., Preston-Campbell, R., Bachi, K., Alia-Klein, N., & Goldstein, R. Z. (2018). Neural correlates of drug-biased choice in currently-using and abstinent individuals with cocaine use disorder. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 3(5), 485-494. PMCID: PMC5944613.
Moeller, S. J., Okita, K., Robertson, C. L., Ballard, M. E., Johnson, M., Konova, A. B., Goldstein, R. Z., Mandelkern, M. A., & London E. D. (2018). Low striatal dopamine D2-type receptor availability is linked to simulated drug choice in methamphetamine users. Neuropsychopharmacology, 43(4), 751-760. PMCID: PMC5809782.
Moeller, S. J. & Paulus, M. P. (2018). Toward biomarkers of the addicted human brain: Using neuroimaging to predict relapse and sustained abstinence in substance use disorder. Progress in Neuropsychopharmacology and Biological Psychiatry, 80(Pt B), 143-154. PMCID: PMC5603350.
Moeller, S. J., Fleming, S. M., Gan, G., Zilverstand, A., Malaker, P. d'Oleire Uquillas, F., Schneider, K. E., Preston-Campbell, R., Parvaz, M. A. Maloney, T., Alia-Klein, N., & Goldstein, R. Z. (2016). Metacognitive impairment in cocaine dependence is associated with individual differences in brain structure. European Neuropsychopharmacology, 26(4), 653-662. PMCID: PMC4805109.
Moeller, S. J., & Goldstein, R. Z. (2014). Impaired self-awareness in human addiction: Deficient attribution of personal relevance. Trends in Cognitive Sciences, 18(12), 635-641. PMCID: PMC4254155.
Moeller, S. J., Konova, A. B., Parvaz, M. A., Tomasi, D., Lane, R. D., Fort, C., & Goldstein, R. Z. (2014). Functional, structural, and emotional correlates of impaired insight in cocaine addiction. JAMA Psychiatry, 71(1), 61-70. PMCID: PMC4193926.
Moeller, S. J., Hajcak, G., Parvaz, M. A., Dunning, J. P., Volkow, N. D., & Goldstein, R. Z. (2012). Psychophysiological prediction of choice: relevance to insight and drug addiction. Brain, 135(Pt 11), 3481-3494. PMCID: PMC3501972.
Moeller, S. J., Tomasi, D., Woicik, P. A., Maloney, T., Alia-Klein, N., Honorio, J., Telang, F., Wang, G.-J., Wang, R., Sinha, R., Carise, D., Astone-Twerell, J., Bolger, J., Volkow, N. D., & Goldstein, R. Z. (2012). Enhanced midbrain response at 6-month follow-up in cocaine addiction, association with reduced drug-related choice. Addiction Biology, 17(6), 1013-1025. PMCID: PMC3394885.
Moeller S. J., Maloney T., Parvaz M. A., Alia-Klein N., Woicik P. A., Telang F., Wang G-J., Volkow N. D., & Goldstein R. Z. (2010). Impaired insight in cocaine addiction: Laboratory evidence and effects on cocaine-seeking behavior. Brain, 133(5), 1484-1493. PMCID: PMC2912695.
Moeller, S. J., Maloney, T., Parvaz, M. A., Dunning, J. P., Alia-Klein, N., Woicik, P. A., Hajcak, G., Telang, F., Wang, G.-J., Volkow, N. D., & Goldstein, R. Z. (2009). Enhanced choice for viewing cocaine pictures in cocaine addiction. Biological Psychiatry, 66(2), 169-176. PMCID: PMC2742172.
|